A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

Semaglutide is a powerful aid for managing weight and Type 2 diabetes, but it’s not a free pass to stick with old habits—or skip taking action altogether. If you’ve been struggling with weight loss, ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity ...

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes.

Adults with obesity receiving once-weekly semaglutide 7.2 mg lost a higher proportion of their body weight at 72 weeks than ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.